Tullamarine Vaccine Plant Opens | Brimbank & North West
4 Articles
4 Articles
Australia locks in home-grown vaccine power with new Melbourne plant - The Indian Sun
Australia’s domestic vaccine capacity has taken a clear step forward with the opening of a major new cell-based vaccine manufacturing facility in Victoria. The Melbourne plant, operated by CSL Seqirus, is the first of its kind in the Southern Hemisphere and is being positioned as a cornerstone of the country’s long-term health security. The facility will produce seasonal and pandemic influenza vaccines, antivenoms and the Q-Fever vaccine. These …
Melbourne opens $1bn vaccine facility
Image: wacomka/stock.adobe.comAustralia has taken a major step forward in onshore vaccine production with the opening of CSL Seqirus’ cutting-edge cell-based influenza vaccine and antivenom manufacturing facility in Melbourne. The facility was inaugurated today by The Hon Mark Butler MP, minister for health, disability and ageing. The Australian-owned and operated site is the only cell-based influenza vaccine manufacturing facility in the Southe…
Tullamarine vaccine plant opens
The Southern Hemisphere’s first cell-based vaccine manufacturing facility has opened in Tullamarine. The new CSL Seqirus facility will be able to supply Australia with critical health products, including pandemic and seasonal influenza vaccines, lifesaving antivenoms and Q-Fever vaccines. The $1 billion, ten-year agreement between the… Read more The post Tullamarine vaccine plant opens appeared first on Star Weekly.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium

